[关键词]
[摘要]
目的 以光敏剂二氢卟吩e6(chlorin e6,Ce6)修饰人血清白蛋白(human serum albumin,HSA)为载体,负载抗肿瘤药物紫杉醇(paclitaxel,PTX)后构建纳米给药系统PTX@HSA-Ce6,以实现肿瘤“化疗-光动力”联合治疗,改善乳腺癌治疗效果。方法 共价结合法制备HSA-Ce6,红外光谱、紫外-可见吸收光谱和荧光光谱进行表征;自组装法制备载药纳米粒PTX@HSA-Ce6,对其粒径分布、表面ζ电位、形貌及稳定性进行表征,研究其药物负载和释放行为;利用乳腺癌MCF-7细胞模型考察PTX@HSA-Ce6的活性氧产生、细胞摄取及体外抗肿瘤效果。结果 当HSA与Ce6投料比为1:10时,制备得到的PTX@HSA-Ce6呈规整的球形,平均粒径为(147.4±0.9)nm,ζ电位为(—15.2±0.6)mV,具有良好的稳定性。PTX@HSA-Ce6可有效负载紫杉醇,具有pH敏感性药物缓释效果。PTX@HSA-Ce6可被MCF-7细胞快速、持续摄取,激光照射下可在胞内产生活性氧,与紫杉醇发挥联合抗肿瘤作用。结论 PTX@HSA-Ce6可实现对Ce6和紫杉醇的共载和胞内递送,发挥化疗-光动力治疗联合抗肿瘤作用,有利于改善乳腺癌的治疗效果。
[Key word]
[Abstract]
Objective A paclitaxel (PTX)-loaded nano-drug delivery system based on chlorin e6 (Ce6)-conjugated human serum albumin (HSA) was prepared for chemo-photodynamic combined therapy of breast cancer to improve therapeutic efficacy. Methods HSA-Ce6 conjugates were prepared by covalent coupling method, and their FT-IR spectra, UV-vis absorption spectra and fluorescence spectra were analyzed. Paclitaxel-loaded HSA-Ce6 nanoparticles (PTX@HSA-Ce6) were prepared by self-assembling and their particle distribution,ζ potential, morphology and stability were characterized. The drug loading and release profiles of PTX@HSA-Ce6 were examined. The in vitro intracellular reactive oxygen species (ROS) generation, cellular uptake and cytotoxicity of PTX@HSA-Ce6 were evaluated on human breast cancer MCF-7 cells.Results PTX@HSA-Ce6 prepared with a HSA/Ce6 molar ratio of 1:10 displayed uniformly spherical shape and good stability with a mean particle size of (147.4 ±0.9) nm and ζ potential of (−15.2 ±0.6) mV. PTX@HSA-Ce6 could efficiently load paclitaxel and showed sustained drug release behaviors with pH-sensitivity. PTX@HSA-Ce6 could be rapidly and continuously taken up by MCF-7 cells, and generated intracellular ROS after laser irradiation. MTT assay indicated that PTX@HSA-Ce6 exhibited significantly higher inhibitory effect on the in vitro proliferation of MCF-7 cells compared with the single treatment of paclitaxel or HSA-Ce6. Conclusion PTX@HSA-Ce6 could facilitate the co-loading and intracellular delivery of Ce6 and paclitaxel, therefore enhance the therapeutic efficacy of breast cancer by chemo-photodynamic combined therapy.
[中图分类号]
R283.6
[基金项目]
国家自然科学基金资助项目(81703391);山东省自然科学基金重点项目(ZR2020KB015);山东省自然科学基金项目(ZR2021MC091);山东省青创人才引育团队—中药复杂体系作用模式解析创新研究团队项目(10073004);山东省大学生创新创业训练计划(S202010440063);山东省大学生创新创业训练计划(S202110440055)